| Organisation overview | |
|---|---|
| Formed | 2010[citation needed] |
| Type | Regulatory body |
| Parent department | Indian Pharmacopoeia Commission |
| Website | cdsco |
The Pharmacovigilance Programme of India (PvPI) is an Indian government organization which identifies and responds to drug safety problems.[1] Its activities include receiving reports of adverse drug events and taking necessary action to remedy problems.[1] The Central Drugs Standard Control Organisation established the program in July 2010 [1][2] with All India Institute of Medical Sciences, New Delhi as the National Coordination Centre, which later shifted to Indian Pharmacopoeia Commission in Ghaziabad on 15 April 2011.[1][2]
- ^ a b c d Indian Pharmacopoeia Commission (2014). "Guidance Document for Spontaneous Adverse Drug Reaction Reporting" (PDF). p. 2.
- ^ a b Cite error: The named reference
Thatte 2018was invoked but never defined (see the help page).